Optima Medical Innovations Corp. (OMIC)
Feb 21, 2025 - OMIC was delisted (reason: acquired by Deerfield)
20.01
0.00 (0.00%)
Inactive · Last trade price on Feb 20, 2025
Singular Genomics Systems Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Singular Genomics Systems stock had an average target of 10.75, with a low estimate of 6.50 and a high estimate of 15.
Price Target: $10.75 (-46.28%)
Analyst Consensus: Hold
No price target forecast data available
* Price targets were last updated on Jul 9, 2024.
Analyst Ratings
The average analyst rating for Singular Genomics Systems stock from 2 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $23 → $6.5 | Hold | Maintains | $23 → $6.5 | -67.52% | Jul 9, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $26 → $23 | Hold | Maintains | $26 → $23 | +12.44% | May 15, 2024 |
| UBS | UBS | Hold Maintains $12 → $15 | Hold | Maintains | $12 → $15 | -25.04% | Mar 20, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $29 → $26 | Hold | Maintains | $29 → $26 | +27.44% | Jan 23, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $29 → $26 | Hold | Maintains | $29 → $26 | +27.44% | Jan 22, 2024 |
Financial Forecast
Revenue This Year
2.94M
from 2.91M
Increased by 0.82%
Revenue Next Year
10.35M
from 2.94M
Increased by 252.64%
EPS This Year
-34.66
from -39.08
EPS Next Year
-32.25
from -34.66
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.5M | 16.0M | |
| Avg | 2.9M | 10.4M | |
| Low | 2.4M | 5.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 21.0% | 443.6% | |
| Avg | 0.8% | 252.6% | |
| Low | -19.2% | 70.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -35.19 | -32.84 | |
| Avg | -34.66 | -32.25 | |
| Low | -33.76 | -31.31 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.